Literature DB >> 8772491

Contribution of net hepatic glycogenolysis to glucose production during the early postprandial period.

K F Petersen1, T Price, G W Cline, D L Rothman, G I Shulman.   

Abstract

Relative contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production during the first 12 h of a fast were studied in 13 healthy volunteers by noninvasively measuring hepatic glycogen content using 13C nuclear magnetic resonance spectroscopy. Rates of net hepatic glycogenolysis were calculated by multiplying the change in liver glycogen content with liver volume determined by magnetic resonance imaging. Rates of gluconeogenesis were calculated as the difference between rates of glucose production determined with an infusion of [6,6-2H]-glucose and net hepatic glycogenolysis. At 6 P.M. a liquid mixed meal (1,000 kcal; 60% as glucose) was given, to which [2-2H]glucose was added to trace glucose absorption. Hepatic glycogen content was measured between 11 P.M. and 1 A.M. and between 3 and 6 A.M. At 11 P.M. the concentration was 470 mM and it decreased linearly during the night. The mean liver volume was 1.47 +/- 0.06 liters. Net hepatic glycogenolysis (5.8 +/- 0.8 mumol.kg body wt-1.min-1) accounted for, on average, 45 +/- 6% and gluconeogenesis for 55 +/- 6% of the rate of whole body glucose production (12.6 +/- 0.6 mumol.kg body wt-1.min-1). In conclusion, this study shows that, even early in the phase of the postabsorptive period when liver glycogen stores are maximal, gluconeogenesis contributes approximately 50% to hepatic glucose production.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8772491     DOI: 10.1152/ajpendo.1996.270.1.E186

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  28 in total

Review 1.  Is hepatic glucose production increased in type 2 diabetes mellitus?

Authors:  Henning Beck-Nielsen; Ole Hother-Nielsen; Peter Staehr
Journal:  Curr Diab Rep       Date:  2002-06       Impact factor: 4.810

Review 2.  The use of magnetic resonance methods in translational cardiovascular research.

Authors:  Arthur H L From; Kamil Ugurbil
Journal:  J Cardiovasc Transl Res       Date:  2009-01-13       Impact factor: 4.132

3.  Glucose turnover and gluconeogenesis in human pregnancy.

Authors:  S Kalhan; K Rossi; L Gruca; E Burkett; A O'Brien
Journal:  J Clin Invest       Date:  1997-10-01       Impact factor: 14.808

Review 4.  The mitochondrial isoform of phosphoenolpyruvate carboxykinase (PEPCK-M) and glucose homeostasis: has it been overlooked?

Authors:  Romana Stark; Richard G Kibbey
Journal:  Biochim Biophys Acta       Date:  2013-10-28

5.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects.

Authors:  X Chen; N Iqbal; G Boden
Journal:  J Clin Invest       Date:  1999-02       Impact factor: 14.808

6.  Mechanism by which glucose and insulin inhibit net hepatic glycogenolysis in humans.

Authors:  K F Petersen; D Laurent; D L Rothman; G W Cline; G I Shulman
Journal:  J Clin Invest       Date:  1998-03-15       Impact factor: 14.808

7.  Effect of macronutrients, age, and obesity on 6- and 24-h postprandial glucose metabolism in cats.

Authors:  Margarethe Hoenig; Erin T Jordan; John Glushka; Saskia Kley; Avinash Patil; Mark Waldron; James H Prestegard; Duncan C Ferguson; Shaoxiong Wu; Darin E Olson
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-09-21       Impact factor: 3.619

Review 8.  Mechanisms of Insulin Action and Insulin Resistance.

Authors:  Max C Petersen; Gerald I Shulman
Journal:  Physiol Rev       Date:  2018-10-01       Impact factor: 37.312

Review 9.  Regulation of Glucose Production in the Pathogenesis of Type 2 Diabetes.

Authors:  Ashot Sargsyan; Mark A Herman
Journal:  Curr Diab Rep       Date:  2019-08-03       Impact factor: 4.810

10.  Regulation of net hepatic glycogenolysis and gluconeogenesis during exercise: impact of type 1 diabetes.

Authors:  Kitt Falk Petersen; Thomas B Price; Raynald Bergeron
Journal:  J Clin Endocrinol Metab       Date:  2004-09       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.